ApoB (XbaI) polymorphism and lipid variation in Teharnian population

被引:3
作者
Daneshpour, Maryam S. [1 ]
Faam, Bita [1 ]
Hedayati, Mehdi [1 ]
Eshraghi, Parisa [1 ]
Azizi, Fereidoun [1 ]
机构
[1] Shaheed Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran
基金
美国国家科学基金会;
关键词
apo B polymorphism; Iran; lipid; Tehran Lipid and Glucose Study (TLGS); DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; HUMAN APOLIPOPROTEIN-B; CORONARY-HEART-DISEASE; PRECIPITATION PROCEDURE; TEHRANIAN POPULATION; HDL CHOLESTEROL; GENE; PLASMA; ASSOCIATION;
D O I
10.1002/ejlt.201000346
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
This study examines the association of XbaI apolipoprotein B polymorphism with lipid related variables in Tehran lipid and glucose study. 809 subjects from the TLGS population were selected, anthropometrical and biochemical factors were measured. A segment of the apo B gene in exon 26 was amplified by PCR and the polymorphism was revealed by RFLP using XbaI restriction enzyme. Allele frequencies obtained for X(+) and X(-) were 27.6 and 72.4%, respectively. Presence of the X(+) allele was significantly associated with increased levels of total cholesterol (p 0.048), apolipoprotein B (p 0.018), and low-density lipoprotein (p 0.022). The associations were significant even after adjustment for age, BMI, smoking, and history of diabetes. There are some relationships between the presence of different alleles of XbaI polymorphism with serum cholesterol, apoB, and LDL-C concentration. These findings highlight the importance of variation in this gene on some lipid related factors levels.
引用
收藏
页码:436 / 440
页数:5
相关论文
共 35 条
  • [21] COMPLETE PROTEIN-SEQUENCE AND IDENTIFICATION OF STRUCTURAL DOMAINS OF HUMAN APOLIPOPROTEIN-B
    KNOTT, TJ
    PEASE, RJ
    POWELL, LM
    WALLIS, SC
    RALL, SC
    INNERARITY, TL
    BLACKHART, B
    TAYLOR, WH
    MARCEL, Y
    MILNE, R
    JOHNSON, D
    FULLER, M
    LUSIS, AJ
    MCCARTHY, BJ
    MAHLEY, RW
    LEVYWILSON, B
    SCOTT, J
    [J]. NATURE, 1986, 323 (6090) : 734 - 738
  • [22] LAW A, 1986, LANCET, V1, P1301
  • [23] Inflammation in Atherosclerosis
    Libby, Peter
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (09) : 2045 - 2051
  • [24] LUDWIG EH, 1989, AM J HUM GENET, V45, P458
  • [25] LUSIS AJ, 1988, J LIPID RES, V29, P397
  • [26] Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
    Murray, CJL
    Lopez, AD
    [J]. LANCET, 1997, 349 (9063) : 1436 - 1442
  • [27] HYPERLIPIDEMIA AND ATHEROSCLEROSIS
    ROSS, R
    HARKER, L
    [J]. SCIENCE, 1976, 193 (4258) : 1094 - 1100
  • [28] Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training
    Ruaño, G
    Seip, RL
    Windemuth, A
    Zöllner, S
    Tsongalis, GJ
    Ordovas, J
    Otvos, J
    Bilbie, C
    Miles, M
    Zoeller, R
    Visich, P
    Gordon, P
    Angelopoulos, TJ
    Pescatello, L
    Moyna, N
    Thompson, PD
    [J]. ATHEROSCLEROSIS, 2006, 185 (01) : 65 - 69
  • [29] Singh VP, 2006, AM J BIOCH BIOTECHNO, V2, P138
  • [30] Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
    Sniderman, AD
    Furberg, CD
    Keech, A
    van Lennep, JER
    Frohlich, J
    Jungner, I
    Walldius, G
    [J]. LANCET, 2003, 361 (9359) : 777 - 780